These authors contributed equally to this study
The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma†
Version of Record online: 3 MAY 2013
Copyright © 2013 American Association for the Study of Liver Diseases
Volume 57, Issue 6, pages 2261–2273, June 2013
How to Cite
Sieghart, W., Hucke, F., Pinter, M., Graziadei, I., Vogel, W., Müller, C., Heinzl, H., Trauner, M. and Peck-Radosavljevic, M. (2013), The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma. Hepatology, 57: 2261–2273. doi: 10.1002/hep.26256
Potential conflict of interest: W. Sieghart received speaker and consulting fees and research grants from Bayer Schering Pharma; H. Heinzl received a research grant from Roche; M. Trauner received speaker fees and travel grants from Roche; M. Peck-Radosavljevic received speakers and consulting fees and research grants from Bayer Schering Pharma, Lilly Pharma, and Boehringer Ingelheim.
- Issue online: 12 JUN 2013
- Version of Record online: 3 MAY 2013
- Accepted manuscript online: 12 JAN 2013 07:09AM EST
- Manuscript Accepted: 18 DEC 2012
- Manuscript Received: 27 AUG 2012
Additional Supporting Information may be found in the online version of this article.
|HEP_26256_sm_SuppTab.doc||38K||Supporting Information Table|
|HEP_26256_sm_SuppFig2.tif||2204K||Supporting Information Figure 2b|
|HEP_26256_sm_SuppFig3.tif||975K||Supporting Information Figure 3|
|HEP_26256_sm_SuppCap.doc||23K||Supporting Information Legends|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.